Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in GALT — Galectin Therapeutics Inc

CIK 73124 CHICAGO, IL
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,793,567
+$1,429,618 QoQ
Shares Held
386,545
+196.3% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 98 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. GALT ranks #236 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in GALT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,793,567 386,545
2026-03-31 $363,949 130,448
2025-12-31 $542,663 130,448
2025-09-30 $513,314 121,065
2025-06-30 $254,763 120,741
2025-03-31 $207,676 170,227
2024-12-31 $315,112 244,274
2024-09-30 $644,270 234,280
2024-06-30 $286,961 126,974
2024-03-31 $241,750 101,151
2023-12-31 $167,695 101,022
2023-09-30 $195,770 101,964
2023-06-30 $146,828 101,964
2023-03-31 $198,991 94,758
2022-12-31 $95,894 84,863
2022-09-30 $138,961 85,253
2022-06-30 $117,717 89,861
2022-03-31 $150,595 93,538
2021-12-31 $194,554 93,988
2021-09-30 $344,621 88,820
2021-06-30 $308,063 96,270
2021-03-31 $913,792 421,103
2020-12-31 $1,014,622 452,957
2020-09-30 $1,244,122 465,964
2020-06-30 $1,512,707 494,349
2020-03-31 $1,013,385 517,034